Chromium Supplementation Does Not Improve Glucose Tolerance, Insulin Sensitivity, or Lipid Profile: A Randomized, Placebo-Controlled, Double-Blind Trial of Supplementation in Subjects With Impaired Glucose Tolerance
Response to Gunton et al.
- James Komorowski, MS and
- Vijaya Juturu, PHD
- Technical Services & Scientific Affairs Department, Nutrition 21, Inc., Purchase, New York
- Address correspondence to Vijaya Juturu, PhD, Nutrition 21, Inc., 4 Manhattanville Rd., Purchase, NY 10577. E-mail: vjuturu{at}nutrition21.com
We read the recent article by Gunton et al. (1) with great interest and feel that it warrants comment. In this study, the authors stated that they “found no beneficial effect of chromium supplementation in the treatment of people with IGT [impaired glucose tolerance].” The results are in conflict with other clinical studies that showed chromium picolinate can enhance or normalize impaired glucose metabolism, as described in a recent review (2). The lack of effect described by the authors may be …
